title: AIDS costs remain problematic despite improvements in therapy.
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000191:economics*; D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D003363:Cost Control; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D008329:Managed Care Programs / Q000191:economics; D012308:Risk Management; D014481:United States
chemical_list: D019380:Anti-HIV Agents